Table 2.
Number | Name of the Disease Entity | CD-68-Positive Macrophage Density in Renal Cortex |
CD-163-Positive Macrophage Density in Both Renal Cortex and Medulla |
CD-14-Positive Monocyte Density in Renal Cortex |
---|---|---|---|---|
1 | Small vessel vasculitis [4] |
|
|
|
2 | IgA Nephropathy [4,5,6] | |||
3 | Hypertension [4] | |||
4 | Membranous glomerulonephritis [4] | |||
5 | Focal segmental glomerulosclerosis [4] | |||
6 | Thrombotic micro-angiopathy [4] | |||
7 | Minimal change disease [4] | |||
8 | Tubulo-interstitial nephritis [4] | |||
9 | Diabetic nephropathy [4] | |||
10 | Systemic lupus erythematosus [4,7,8,9] | |||
11 | Urinary tract infection [4] | |||
12 | Amyloidosis [4] | |||
13 | Post-infectious glomerulonephritis [4,9] | |||
14 | Thin basement membrane disease—Alport disease [4] | |||
15 | Other diseases * [4] |
* Other diseases [4]—C1q/Mesangio-proliferative GN, C3GN, para-infectious mesangio-proliferative GN, light chain nephropathy, nicotine induced nodular glomerulosclerosis, lupus like nephritis, feto-fetal-transfusion syndrome, associated multi-organ failure, atypical hemolytic uremic syndrome, tubular dysgenesis. Note: CD-68, CD-163 and CD-14 have been studied extensively in animal models and are now validated for diagnostic and prognostic biomarker application in human biopsies as well as for research. CD-68 and CD-163 have cytoplasmic expression while CD-14 has a nuclear expression. Recent evidence highlights the presence of CD-14 in clear cell renal cell carcinoma cells in addition to the monocyte lineage. Higher CD-14 expression in the peri-tumoral immune infiltrate is associated with poorer prognosis. Several studies have documented high density of CD-68-positive macrophages in tubulo-interstitial region in correlation with poor long term renal survival in IgA nephropathy and SLE nephritis [4,5,6,7,8,9].